ICM
BHC icon

Invenomic Capital Management’s Bausch Health BHC Stock Holding History

Invenomic Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,400
Closed -$123K – 149
2022
Q1 		$123K Buy
+5,400
New +$132K 0.01% 153
2020
Q2 		– Sell
-303
Closed -$57K – 157
2020
Q1 		$57K Sell
303
-60
-17% -$1.45K 0.05% 147
2019
Q4 		$456K Buy
+363
New +$9.44K 0.18% 99

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Invenomic Capital Management's BHC Position: Q2 2022 in Review

Invenomic Capital Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 288,964 shares — an estimated $5.27M sold.

Invenomic Capital Management first reported a position in BHC in Q4 2019 and held it in 10 quarters. The position peaked at $8.01M in Q4 2019. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Invenomic Capital Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 288,964 Bausch Health shares in Q2 2022, an estimated $5.27M.
  • Invenomic Capital Management first reported a position in Bausch Health in Q4 2019 and held it in 10 quarters.
  • Invenomic Capital Management's Bausch Health position peaked at $8.01M in Q4 2019.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.